Search alternatives:
significant gender » significant concern (Expand Search), significant burden (Expand Search)
gender decrease » greater decrease (Expand Search), teer decrease (Expand Search)
significant a » significant _ (Expand Search), significant i (Expand Search), significant all (Expand Search)
Showing 1 - 20 results of 17,967 for search '(( significant gender decrease ) OR ( ((significant a) OR (significant gap)) decrease ))', query time: 0.64s Refine Results
  1. 1
    Lecturers by gender.

    Lecturers by gender. by Ignacio García-Espona (21395335)

    Published 2025
    “…The COVID-19 pandemic resulted in a significant reduction in the number of poster presentations. …”
    Save to List
    Saved in:
  2. 2
    Posters by gender.

    Posters by gender. by Ignacio García-Espona (21395335)

    Published 2025
    “…The COVID-19 pandemic resulted in a significant reduction in the number of poster presentations. …”
    Save to List
    Saved in:
  3. 3
    Comparative Analysis of Chills Experience Across Three Groups: This table presents a detailed comparison of three groups (A, B, and C) in terms of their experiences with chills. It includes the number of participants in each group, frequency, intensity, and duration of chills, along with demographics such as gender, age, race, education level, and income. Statistical significance (p-value) is also provided for each category.

    Comparative Analysis of Chills Experience Across Three Groups: This table presents a detailed comparison of three groups (A, B, and C) in terms of their experiences with chills. It... by Felix Alexandre Schoeller (20988295)

    Published 2025
    Save to List
    Saved in:
  4. 4
    Gender-specific incidence trends of HFMD in Guangzhou from 2013 to 2023.

    Gender-specific incidence trends of HFMD in Guangzhou from 2013 to 2023. by Haipeng Luo (5322419)

    Published 2025
    Save to List
    Saved in:
  5. 5
    iKIR score decreases protection associated with protective class II genotypes in T1D.

    iKIR score decreases protection associated with protective class II genotypes in T1D. by Laura Mora-Bitria (20477525)

    Published 2024
    Save to List
    Saved in:
  6. 6
    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  7. 7
    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  8. 8
    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  9. 9
    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx

    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  10. 10
    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  11. 11
    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  12. 12
    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg

    Image 1_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  13. 13
    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx

    Table 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx by Ling Kui (6108440)

    Published 2025
    “…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …”
    Save to List
    Saved in:
  14. 14
    Trends in the age-standardized rate of YLDs per 100,000 caused by smoking-related strokes in Saudi Arabia during 1990–2021, stratified by gender.

    Trends in the age-standardized rate of YLDs per 100,000 caused by smoking-related strokes in Saudi Arabia during 1990–2021, stratified by gender. by Jaber S. Alqahtani (8822396)

    Published 2025
    Save to List
    Saved in:
  15. 15
    Trends in age-standardized rate of DALYs per 100,000 with caused by smoking-related strokes in Saudi Arabia during 1990–2021, stratified by gender.

    Trends in age-standardized rate of DALYs per 100,000 with caused by smoking-related strokes in Saudi Arabia during 1990–2021, stratified by gender. by Jaber S. Alqahtani (8822396)

    Published 2025
    Save to List
    Saved in:
  16. 16
    Trends in the age-standardized rate of YLLs per 100,000 caused by smoking-related strokes in Saudi Arabia during 1990–2021, stratified by gender.

    Trends in the age-standardized rate of YLLs per 100,000 caused by smoking-related strokes in Saudi Arabia during 1990–2021, stratified by gender. by Jaber S. Alqahtani (8822396)

    Published 2025
    Save to List
    Saved in:
  17. 17
    Trends in age-standardized rate of deaths per 100,000 caused by smoking-related strokes in Saudi Arabia during 1990–2021, stratified by gender.

    Trends in age-standardized rate of deaths per 100,000 caused by smoking-related strokes in Saudi Arabia during 1990–2021, stratified by gender. by Jaber S. Alqahtani (8822396)

    Published 2025
    Save to List
    Saved in:
  18. 18
    Decrease of cellular cAMP levels in response to a concentration range of melatonin treatments.

    Decrease of cellular cAMP levels in response to a concentration range of melatonin treatments. by Cathryn S. D. Maienza (20629929)

    Published 2025
    Save to List
    Saved in:
  19. 19
    Proportion of PUD DALYs and deaths attributable to smoking by gender, SDI quintile, and GBD region in 1990 and 2021.

    Proportion of PUD DALYs and deaths attributable to smoking by gender, SDI quintile, and GBD region in 1990 and 2021. by Wende Hao (10315597)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 20
    Total number of applications to each discipline grouped by (a) clinical disciplines, (b) diagnostic disciplines, and (c) surgical disciplines.

    Total number of applications to each discipline grouped by (a) clinical disciplines, (b) diagnostic disciplines, and (c) surgical disciplines. by Lucy Hui (17538542)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: